Henry Schein (NASDAQ:HSIC) Earns “Outperform” Rating from Barrington Research

Barrington Research restated their outperform rating on shares of Henry Schein (NASDAQ:HSIC) in a report issued on Wednesday morning,Benzinga reports. The firm currently has a $82.00 price objective on the stock. Barrington Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.20 EPS, FY2024 earnings at $4.75 EPS, Q1 2025 earnings at $1.12 EPS, Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.27 EPS, Q4 2025 earnings at $1.46 EPS, FY2025 earnings at $5.12 EPS and FY2026 earnings at $5.80 EPS.

A number of other equities analysts have also issued reports on HSIC. Robert W. Baird decreased their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI upped their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $77.50.

Henry Schein Price Performance

Shares of HSIC opened at $68.00 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.90. The company has a market cap of $8.48 billion, a P/E ratio of 27.98, a PEG ratio of 2.00 and a beta of 0.87. Henry Schein has a 12 month low of $62.12 and a 12 month high of $82.63. The stock has a fifty day moving average price of $70.51 and a 200 day moving average price of $69.73.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.32 earnings per share. On average, research analysts forecast that Henry Schein will post 4.76 earnings per share for the current year.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

A number of hedge funds have recently modified their holdings of the business. Cromwell Holdings LLC lifted its position in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares in the last quarter. Summit Securities Group LLC purchased a new stake in Henry Schein in the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA acquired a new stake in shares of Henry Schein during the 2nd quarter valued at $37,000. Blue Trust Inc. grew its holdings in shares of Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.